Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration.

چکیده

Practice patterns for neovascular age-related macular degeneration (nAMD) have evolved from the landmark registration trials of vascular endothelial growth factor (VEGF) inhibitors. Non-monthly regimens like treat-and-extend (T&E) have become popular due to their effectiveness in clinical practice.…

متن کامل چکیده در سایت ناشر در دسترس است.